Paper30278129
Modular Pore-Forming Immunotoxins with Caged Cytotoxicity Tailored by Directed Evolution.
Mutter NL and 5 others. ACS Chem Biol, 2018. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Modular Pore-Forming Immunotoxins with Caged Cytotoxicity Tailored by Directed Evolution. Papers, record 30278129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30278129
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Modular Pore-Forming Immunotoxins with Caged Cytotoxicity Tailored by Directed Evolution.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cnidarian Venoms | Major topic |
| Immunotoxins | Major topic |
| Pore Forming Cytotoxic Proteins | Major topic |
| Recombinant Fusion Proteins | Major topic |
| Tetrahydrofolate Dehydrogenase | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Cell Membrane | |
| Directed Molecular Evolution | |
| Drug Design | |
| Escherichia coli | |
| Folic Acid | |
| Furin | |
| Humans | |
| Mutagenesis | |
| Proteolysis | |
| Salmonella typhi | |
| Sea Anemones |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18511069 | Engineered bacterial outer membrane vesicles with enhanced functionality. | J Mol Biol | 2008 | https://conductscience.org/library/papers/18511069 | PubMed |
| 2 | 10675719 | Unraveling the role of proteases in cancer. | Clin Chim Acta | 2000 | https://conductscience.org/library/papers/10675719 | PubMed |
| 3 | 18418218 | Potentiation of anticancer-drug cytotoxicity by sea anemone pore-forming proteins in human glioblastoma cells. | Anticancer Drugs | 2008 | https://conductscience.org/library/papers/18418218 | PubMed |
| 4 | 23808764 | Radionuclide antibody-conjugates, a targeted therapy towards cancer. | Curr Radiopharm | 2013 | https://conductscience.org/library/papers/23808764 | PubMed |
| 5 | 25997032 | Designing the furin-cleavable linker in recombinant immunotoxins based on Pseudomonas exotoxin A. | Bioconjug Chem | 2015 | https://conductscience.org/library/papers/25997032 | PubMed |
| 6 | 9166946 | Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9166946 | PubMed |
| 7 | 3334101 | Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein. | Protein Eng | 1987 | https://conductscience.org/library/papers/3334101 | PubMed |
| 8 | 8140099 | A pore-forming protein with a protease-activated trigger. | Protein Eng | 1994 | https://conductscience.org/library/papers/8140099 | PubMed |
| 9 | 16862189 | Drug penetration in solid tumours. | Nat Rev Cancer | 2006 | https://conductscience.org/library/papers/16862189 | PubMed |
| 10 | 19234897 | Challenges in monoclonal antibody-based therapies. | Ann Med | 2009 | https://conductscience.org/library/papers/19234897 | PubMed |
| 11 | 10209277 | Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. | Biochim Biophys Acta | 1999 | https://conductscience.org/library/papers/10209277 | PubMed |
| 12 | 11597399 | EGFR and cancer prognosis. | Eur J Cancer | 2001 | https://conductscience.org/library/papers/11597399 | PubMed |
| 13 | 27299281 | Antibody-drug conjugates for cancer therapy. | Lancet Oncol | 2016 | https://conductscience.org/library/papers/27299281 | PubMed |
| 14 | 20647768 | Recovery and purification process development for monoclonal antibody production. | MAbs | 2010 | https://conductscience.org/library/papers/20647768 | PubMed |
| 15 | 11920600 | Efficient tumor targeting by single-domain antibody fragments of camels. | Int J Cancer | 2002 | https://conductscience.org/library/papers/11920600 | PubMed |
| 16 | 11102891 | Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients. | Int J Cancer | 2000 | https://conductscience.org/library/papers/11102891 | PubMed |
| 17 | 2785509 | A carcinoembryonic antigen-directed immunotoxin built by linking a monoclonal antibody to a hemolytic toxin. | Int J Cancer | 1989 | https://conductscience.org/library/papers/2785509 | PubMed |
| 18 | 18041103 | Recombinant therapeutic proteins: production platforms and challenges. | Biotechnol J | 2008 | https://conductscience.org/library/papers/18041103 | PubMed |
| 19 | 25561510 | Advances in anticancer immunotoxin therapy. | Oncologist | 2015 | https://conductscience.org/library/papers/25561510 | PubMed |
| 20 | 18064354 | Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin. | Biol Res | 2007 | https://conductscience.org/library/papers/18064354 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41998209 | Antitumor immunotoxin expression is enhanced by Escherichia coli csrB-promoter activity. | Oncogene | 2026 | https://conductscience.org/library/papers/41998209 | PubMed |
| 41866932 | Bacterial pore-forming toxins: mechanisms and implications for host immunity. | Biosci Rep | 2026 | https://conductscience.org/library/papers/41866932 | PubMed |
| 38318850 | Visible Light Control over the Cytolytic Activity of a Toxic Pore-Forming Protein. | ACS Chem Biol | 2024 | https://conductscience.org/library/papers/38318850 | PubMed |
| 37294530 | Story of Pore-Forming Proteins from Deadly Disease-Causing Agents to Modern Applications with Evolutionary Significance. | Mol Biotechnol | 2024 | https://conductscience.org/library/papers/37294530 | PubMed |
| 36158673 | Bacteria-derived chimeric toxins as potential anticancer agents. | Front Oncol | 2022 | https://conductscience.org/library/papers/36158673 | PubMed |
| 35928456 | Strategies to mitigate the on- and off-target toxicities of recombinant immunotoxins: an antibody engineering perspective. | Antib Ther | 2022 | https://conductscience.org/library/papers/35928456 | PubMed |
| 35651641 | In Vitro Screening for Cytotoxic Effect of Pore Forming Colicin N and Its Domains on Human Cancer Cells. | Trop Life Sci Res | 2022 | https://conductscience.org/library/papers/35651641 | PubMed |
| 35529825 | Cytotoxic effect of sea anemone pore-forming toxin on K562 chronic myeloid leukemia cells. | Vet Res Forum | 2021 | https://conductscience.org/library/papers/35529825 | PubMed |
| 35333704 | Bacterial pore-forming toxins. | Microbiology (Reading) | 2022 | https://conductscience.org/library/papers/35333704 | PubMed |
| 35049929 | Actinoporin-like Proteins Are Widely Distributed in the Phylum Porifera. | Mar Drugs | 2022 | https://conductscience.org/library/papers/35049929 | PubMed |
| 34940653 | Deep-Sea Anemones Are Prospective Source of New Antimicrobial and Cytotoxic Compounds. | Mar Drugs | 2021 | https://conductscience.org/library/papers/34940653 | PubMed |
| 34706833 | Engineered antibody fusion proteins for targeted disease therapy. | Trends Pharmacol Sci | 2021 | https://conductscience.org/library/papers/34706833 | PubMed |
| 34630940 | Resurfacing receptor binding domain of Colicin N to enhance its cytotoxic effect on human lung cancer cells. | Comput Struct Biotechnol J | 2021 | https://conductscience.org/library/papers/34630940 | PubMed |
| 34437438 | Panorama of the Intracellular Molecular Concert Orchestrated by Actinoporins, Pore-Forming Toxins from Sea Anemones. | Toxins (Basel) | 2021 | https://conductscience.org/library/papers/34437438 | PubMed |
| 34131806 | Nanobodies: new avenue to treat kidney disease. | Cell Tissue Res | 2021 | https://conductscience.org/library/papers/34131806 | PubMed |
| 33348592 | Sea Anemone Heteractis crispa Actinoporin Demonstrates In Vitro Anticancer Activities and Prevents HT-29 Colorectal Cancer Cell Migration. | Molecules | 2020 | https://conductscience.org/library/papers/33348592 | PubMed |
| 33255441 | Functional and Structural Variation among Sticholysins, Pore-Forming Proteins from the Sea Anemone Stichodactyla helianthus. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33255441 | PubMed |
| 32252469 | Actinoporins: From the Structure and Function to the Generation of Biotechnological and Therapeutic Tools. | Biomolecules | 2020 | https://conductscience.org/library/papers/32252469 | PubMed |
| 31614771 | Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy against Colorectal Cancer Cells of Ribotoxin α-Sarcin- or RNase T1-Based Immunotoxins. | Toxins (Basel) | 2019 | https://conductscience.org/library/papers/31614771 | PubMed |
| 31469268 | Reversible Photocontrolled Nanopore Assembly. | J Am Chem Soc | 2019 | https://conductscience.org/library/papers/31469268 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTSB | 1508 | PubTator's text mining | https://conductscience.org/library/genes/1508 | NCBI Gene |
| DHFR | 1719 | PubTator's text mining | https://conductscience.org/library/genes/1719 | NCBI Gene |
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| FURIN | 5045 | PubTator's text mining | https://conductscience.org/library/genes/5045 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30278129
GET https://conductscience.org/api/papers/v1/30278129/references?page=2